Julien Blouin

Stock Analyst at Goldman Sachs

(3.26)
# 3,123
Out of 5,182 analysts
30
Total ratings
59.09%
Success rate
1.27%
Average return

Stocks Rated by Julien Blouin

UDR, Inc.
Apr 17, 2026
Maintains: Sell
Price Target: $39$35
Current: $36.39
Upside: -3.82%
Janus Living
Apr 14, 2026
Initiates: Neutral
Price Target: $27
Current: $26.47
Upside: +2.00%
Healthpeak Properties
Jan 9, 2026
Initiates: Neutral
Price Target: $17
Current: $16.42
Upside: +3.53%
Jones Lang LaSalle
Nov 26, 2025
Maintains: Buy
Price Target: $361$407
Current: $315.24
Upside: +29.11%
Camden Property Trust
Sep 17, 2025
Downgrades: Sell
Price Target: $118$106
Current: $104.45
Upside: +1.48%
American Homes 4 Rent
Sep 17, 2025
Downgrades: Neutral
Price Target: $43$37
Current: $31.95
Upside: +15.81%
Cushman & Wakefield
Aug 13, 2025
Maintains: Buy
Price Target: $18$20
Current: $14.11
Upside: +41.74%
Millrose Properties
May 15, 2025
Maintains: Buy
Price Target: $28$32
Current: $30.37
Upside: +3.72%
Invitation Homes
May 6, 2025
Maintains: Buy
Price Target: $39$43
Current: $28.53
Upside: +50.72%
Newmark Group
Mar 19, 2025
Maintains: Buy
Price Target: $20$17
Current: $16.04
Upside: +5.99%
Maintains: Neutral
Price Target: $165$145
Current: $103.63
Upside: +39.92%
Initiates: Buy
Price Target: $176
Current: $141.81
Upside: +24.11%
Initiates: Neutral
Price Target: $318
Current: $263.35
Upside: +20.75%
Initiates: Neutral
Price Target: $81
Current: $65.17
Upside: +24.29%
Initiates: Buy
Price Target: $187
Current: $128.56
Upside: +45.46%